Skip to main content
ZBHZimmer Biomet Holdings, Inc.Hold6.3·$93.75+1.42%

Zimmer Biomet Holdings (ZBH) Q2 2026 earnings — TrendMatrix coverage

BEAT+3.0% vs estimateEPS $2.07 vs $2.01 estCurrent verdict Hold 6.3/10

Reported

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure

Event detail · Q2 2026

Key numbers

Reported EPS
$2.07
Estimate
$2.01
Surprise
+3.0%
Revenue (period 2026-06-30)
$2.18B
Score today
6.3/10

Revenue source: xbrl.

Report record · Q2 2026

How the report landed

Zimmer Biomet Holdings (ZBH) beat the $2.01 estimate with diluted EPS of $2.07 — a modest 3.0% upside surprise.

Current read · as of 2026-09-14

Where TrendMatrix's rating stands now

TrendMatrix currently rates ZBH Hold at 6.3/10; no pre/post engine snapshot brackets this report.

4 of the last 4 quarters beat the estimate; this quarter's +3.0% surprise compares with a +4.5% four-quarter average. Next scheduled report: 2026-11-05.

What supports the rating

  • Sector modifier (Healthcare): +0.5
  • Strong earnings beat streak (4/4)

What argues against it

  • Concentration risk — Supplier: single-source materials and components
  • Thin upside margin: 3.6%
  • Negative momentum

This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.

Current engine read

The levels TrendMatrix's engine tracks

Current price
$93.75
Price target
$96.81
Stop
$88.71
Upside to target
+3.3%
Reward-to-risk
0.6:1

The stock trades at 22.7× trailing but 10.3× forward earnings — consensus estimates already build in a substantial earnings recovery.

Risk check: RSI 26 — a level conventionally read as oversold.

Model outputs from TrendMatrix’s engine as of 2026-09-14 — shown for context, not personalized investment advice.

Healthcare context

ZBH at TrendMatrix's latest read

Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.

Industry
Medical Devices
Market cap
$17.83B
P/E (fwd)
10.3
P/E (ttm)
22.7
52-week range
$79.12$106.88
Off 52-week high
12.3%
RSI (14)
26
Volume vs avg
1.21×
Score today
6.3/10

Earnings figures are sourced from TrendMatrix’s pipeline (EPS: existing earnings extraction; revenue: SEC XBRL company facts where available, yfinance-provisional otherwise). Not a buy/sell rating, a price target, or investment advice — see the current verdict on the stock’s main page for TrendMatrix’s live read.

Home Stocks ZBH Earnings Q2 2026 earnings